EVolution Therapeutics was delighted to have been invited to exhibit at Venturefest 2024. Joining an array of innovative start-ups, Dr James Gavin and Alice Wigington were present throughout the day to talk about the scientific foundation of Evolution Therapeutics’...
Aston University has issued a press release highlighting the work of Evolution Therapeutics and our mission to leverage the pro-resolving properties of extracellular vesicles for the treatment of non-healing wounds, such as diabetic foot ulcers, which impose a...
Exciting news from Evolution Therapeutics as we welcome Alice Wigington, who has joined the team as a Research Scientist. Alice is a first-class graduate of Aston University’s integrated master’s programme in Biological Sciences, bringing strong expertise in...
Evolution Therapeutics has been recognised by the Biotechnology and Biosciences Research Council (BBSRC) in their 2023 impact showcase. This showcase serves as a compilation of impact stories stemming from BBSRC investments, shedding light on significant outcomes...
EVolution Therapeutics is thrilled to announce its selection to join the first cohort of SPARK The Midlands, the inaugural UK branch of the globally recognised Stanford preclinical accelerator model. Collaborating with esteemed partners like Aston University and the...
